Medicine News and Research

RSS

Celladon’s Phase 2 CUPID trial shows improved clinical outcomes in advanced heart failure patients

Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 12-month data from its Phase 2 CUPID clinical trial of MYDICAR demonstrated significant improvements in clinical outcomes and key disease markers in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.

15 Nov 2010

National health disparities conference wraps up with creative approaches, expectations for new healthcare reform

Focusing on the disparities in the quality of health care across demographic groups, the Fourth Annual National Conference on Health Disparities brought together White House officials and national and local healthcare executives to address a series of key questions about non-medical determinants of health quality and to recommend strategies to bring more equitable healthcare access to the underserved. The determinants discussed at the four-day-long conference, which began November 10, 2010 and concluded Saturday, November 13, 2010, included education levels, health literacy, poverty, public safety, community design, access to care, environmental quality and personal, government and corporate responsibility.

15 Nov 2010

Novel heart attack treatment results presented at premier USA cardiology forum

Regenerative medicine company Mesoblast Limited (ASX:MSB; USADR:MBLTY) has announced that positive preclinical trial results were presented at the American Heart Association’s annual conference in Chicago showing that the company’s proprietary “off-the-shelf” stem cells can be injected simply, safely, and effectively into the coronary arteries after a heart attack to prevent heart failure.

15 Nov 2010

Erroneous defibrillators: FDA new initiative to check safety

More problems are being reported in external defibrillators, the life-saving medical devices located in emergency rooms, airports and other public places. These Automated external defibrillators, or AEDs are generally used in patients who have suffered sudden cardiac arrest if used in the first few minutes after their collapse. They deliver electrical energy to the heart to restore its normal rhythm.

15 Nov 2010

Emerging blood thinners to prevent stroke

As blood thinners emerge in the market for stroke prevention many experts believe is still too early to predict how they will stack up in the $15 billion a year market.

15 Nov 2010

MEDecision earns NCQA Healthcare Effectiveness Data and Information Set Software Certification

MEDecision, Inc., a leading provider of collaborative healthcare management solutions, has earned the National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS®) Software Certification for its programs that identify "care opportunities."

15 Nov 2010

BioTime third quarter total revenues increase 82% to $815,284

BioTime, Inc. today reported financial results for the quarter ended September 30, 2010 and provided an update on recent corporate developments.

15 Nov 2010

Biostar third quarter net income increases 9.8% to $3.4 million

Biostar Pharmaceuticals, Inc., Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced financial results for the third quarter ended September 30, 2010.

15 Nov 2010

PGxHealth presents results from studies using FAMILION genetic testing at 2010 AHA

Clinical Data, Inc., today announced that results of studies using its FAMILION® genetic testing were presented at the 2010 American Heart Association (AHA) meeting. PGxHealth, a division of Clinical Data, together with its collaborators, presented results from the largest, most comprehensive studies of genetic variation associated with certain cardiac conditions that were revealed using FAMILION testing.

15 Nov 2010

Weikang third quarter revenue increases 55.2% to record $17.4 million

Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced record fiscal 2010 third quarter results for period ended September 30, 2010.

15 Nov 2010

StemCells seeks Swiss authorization to conduct human neural stem cells clinical trial in chronic spinal cord injury

StemCells, Inc. announced today that is has filed an application with Swissmedic, the Swiss regulatory agency for therapeutic products, to conduct a clinical trial in Switzerland of the Company's HuCNS-SC® purified human neural stem cells in chronic spinal cord injury patients. If authorized, the study would enroll patients who are three to 12 months post-injury.

15 Nov 2010

Titan third quarter net loss decreases to $0.4 million

Titan Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2010.

15 Nov 2010

Nutrastar third quarter revenues increase 81.2% to $6.46 million

Nutrastar International Inc., a leading producer and supplier of premium branded Traditional Chinese Medicine ("TCM") consumer products, today announced financial results for the three and nine months ended September 30, 2010.

15 Nov 2010

No difference in risk of nonsuicide death between ziprasidone and olanzapine for schizophrenia

The potential for harmful side effects associated with anti-psychotic medications for treating schizophrenia is a frustration for mental-health professionals who must balance this with the positive benefits of drugs. For example, the issue of the antipsychotic drug ziprasidone lengthening the QTc interval, a possible indicator of life-threatening heart arrhythmias, has demanded much attention among clinicians since the drug was introduced in 2001.

15 Nov 2010

Adeona third quarter total net revenues increase to $289,898

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced its third quarter 2010 financial results as well as recent clinical and operational achievements.

15 Nov 2010

China Jo-Jo second quarter revenue increases 27.9% to $15.7 million

China Jo-Jo Drugstores, Inc., which operates retail pharmacies in the People's Republic of China, today reported financial results for the second quarter and six month period of fiscal 2011 ended September 30, 2010.

15 Nov 2010

Study analyzes neurological recovery after hypothermia treatment in cardiac arrest patients

Heart experts at Johns Hopkins say that physicians might be drawing conclusions too soon about irreversible brain damage in patients surviving cardiac arrest whose bodies were for a day initially chilled into a calming coma.

15 Nov 2010

AHA/ASA announce need for comprehensive hospital certification program for heart and stroke care

The American Heart Association should develop a comprehensive hospital certification program with policies and evidence-based criteria for cardiovascular disease and stroke care in the United States, according to an American Heart Association Presidential Advisory published in Circulation: Journal of the American Heart Association.

15 Nov 2010

Best ways for proper disposal of unused medicines

Patients in cities all over the country will learn tomorrow about one of the best ways to avoid today's rampant prescription drug abuse – proper disposal of unused medicines.

15 Nov 2010

Research on P450 compound I may help eliminate toxins

Chemical reactions are happening all over the place all the time on the sun, on the Earth and in our bodies. In many cases, enzymes help make these reactions occur. One family of enzymes, called cytochrome P450s (P450), is important because they help us eliminate toxins.

15 Nov 2010

Medicine News and Research

Celladon’s Phase 2 CUPID trial shows improved clinical outcomes in advanced heart failure patients

National health disparities conference wraps up with creative approaches, expectations for new healthcare reform

Novel heart attack treatment results presented at premier USA cardiology forum

Erroneous defibrillators: FDA new initiative to check safety

Emerging blood thinners to prevent stroke

MEDecision earns NCQA Healthcare Effectiveness Data and Information Set Software Certification

BioTime third quarter total revenues increase 82% to $815,284

Biostar third quarter net income increases 9.8% to $3.4 million

PGxHealth presents results from studies using FAMILION genetic testing at 2010 AHA

Weikang third quarter revenue increases 55.2% to record $17.4 million

StemCells seeks Swiss authorization to conduct human neural stem cells clinical trial in chronic spinal cord injury

Titan third quarter net loss decreases to $0.4 million

Nutrastar third quarter revenues increase 81.2% to $6.46 million

No difference in risk of nonsuicide death between ziprasidone and olanzapine for schizophrenia

Adeona third quarter total net revenues increase to $289,898

China Jo-Jo second quarter revenue increases 27.9% to $15.7 million

Study analyzes neurological recovery after hypothermia treatment in cardiac arrest patients

AHA/ASA announce need for comprehensive hospital certification program for heart and stroke care

Best ways for proper disposal of unused medicines

Research on P450 compound I may help eliminate toxins

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News